| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $18777 | $20647 | $24198 | $23442 |
| Inventory | $18532 | $20189 | $20229 | $19317 |
| Total current assets | $93895 | $91796 | $97526 | $99529 |
| Long term investments | ||||
| Property, plant & equipment | $110125 | $109403 | $109462 | $108916 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $284005 | $279488 | $283133 | $283654 |
| Current liabilities | ||||
| Accounts payable | $69384 | $69891 | $70596 | $78062 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $85709 | $82360 | $89157 | $88785 |
| Long term debt | $45750 | $42526 | $38053 | $40478 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $167946 | $162109 | $164724 | $166901 |
| Shareholders' equity | ||||
| Retained earnings | ||||
| Other shareholder equity | -$13793 | -$14415 | -$14167 | -$13701 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14873 | $13544 | $31268 | |
| Short term investments | ||||
| Net receivables | $23442 | $24378 | $55195 | $14068 |
| Inventory | $19317 | $22936 | $19952 | $14730 |
| Total current assets | $99529 | $125724 | $111136 | $79679 |
| Long term investments | ||||
| Property, plant & equipment | $108916 | $107101 | $106559 | $108335 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $186453 | |||
| Total investments | ||||
| Total assets | $283654 | $303864 | $293458 | $266132 |
| Current liabilities | ||||
| Accounts payable | $78062 | $93621 | $36837 | $23574 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $88785 | $109778 | $95102 | $64676 |
| Long term debt | $40478 | $45264 | $48014 | $60203 |
| Total noncurrent liabilities | $95371 | |||
| Total debt | ||||
| Total liabilities | $166901 | $192140 | $181722 | $160047 |
| Shareholders' equity | ||||
| Retained earnings | ||||
| Other shareholder equity | -$13701 | -$12836 | -$12671 | -$7873 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $47429 | $49183 | $51883 | $54765 |
| Cost of revenue | ||||
| Gross Profit | $16004 | $17066 | $18103 | $17615 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $11562 | $11050 | $9230 | $8996 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $2179 | $2725 | $2942 | $3339 |
| Interest expense | -$7 | $310 | -$218 | -$357 |
| Net income | ||||
| Net income | $2229 | $3723 | $5650 | $4992 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $218945 | $263310 | $119704 | |
| Cost of revenue | ||||
| Gross Profit | $75904 | $92261 | $42218 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $42473 | $45029 | $47802 | |
| Operating income | -$5584 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $13301 | $22242 | $318 | |
| Interest expense | $826 | -$3707 | $2147 | |
| Net income | ||||
| Net income | $21090 | $20195 | -$7242 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$13587 | -$8025 | -$3467 | -$16454 |
| Financing activities | ||||
| Dividends paid | -$5719 | -$3756 | -$1903 | -$7517 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$6488 | -$7063 | -$242 | -$29730 |
| Effect of exchange rate | $137 | -$140 | -$83 | -$258 |
| Change in cash and equivalents | -$1591 | -$4052 | -$1623 | -$5763 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | -$7336 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $14803 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$16454 | -$15116 | -$13656 | -$13079 |
| Financing activities | ||||
| Dividends paid | -$7517 | -$9986 | -$8228 | -$6688 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$29730 | -$19272 | -$25497 | $1398 |
| Effect of exchange rate | -$258 | -$1295 | -$1183 | $794 |
| Change in cash and equivalents | -$5763 | $11684 | -$9926 | $3916 |
| Market cap | $139.01B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 2.24B |
| Revenue | $203.26B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $16.59B |
| Revenue Q/Q | -26.99% |
| Revenue Y/Y | N/A |
| P/E ratio | 8.38 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.68 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $7.41 |
|---|---|
| ROA | 5.87% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.10 |
| Quick ratio | 0.88 |